Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Formulation for the treatment of chronic wounds

Innovation Portfolio
Formulation for the treatment of chronic wounds
Download as PDF: | Share:

Problem

Chronic wounds constitute a serious public health problem in Brazil. Difficult to heal, they can remain open for months or even years in patients. Chronic wounds affect over 5 million Brazilians.

Solution

The technology refers to a pro-regenerative hydrogel composed of bioactive stem cell components to enable the cell growth necessary to close difficult-to-heal injuries. Bioactive stem cell components reduce fibrosis, inflammation and pain, and stimulate vascularization. These characteristics inhibit non-functional tissue repair and promote skin regeneration, improving the quality of the patient's scar and recovering the functionality of the affected tissue.

Differential


arrow_circle_up
Greater treatment efficiency
colorize
Easy application
face
Better healing

Development stage


What we are searching for

Partnerships for large-scale cell cultivation (bioreactors) and joint development of the pharmaceutical formulation for production and commercialization of the product.

Inventors

Marco Augusto Stimamiglio
Alejandro Correa Domingues
Amanda Leitolis   
Cintia Delai da Silva Horinouchi
Maria Julia Barison   

 

 

 

Use your phone camera to scan the QR Code:

 

Campus Fiocruz Maré - Av. Brasil, 4036 - Maré, Rio de Janeiro - RJ

CEP: 21040-361

     
  portfolio@fiocruz.br 
     
  +55 (21) 3282-9080 

 

   
   
   

 

Back to the topBack